- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 20.08. | IDL Diagnostics AB: IDL Diagnostics (publ) Interim Report April 1 - June 30, 2026 | 143 | GlobeNewswire (Europe) | A word from the CEO "I am pleased to report that we continued to demonstrate strong sales growth during the second quarter, supported by a robust order intake that provides positive momentum heading... ► Artikel lesen | |
| IDL DIAGNOSTICS Aktie jetzt für 0€ handeln | |||||
| 12.08. | AROCELL Strengthens European Footprint with London Flagship Entry | 2 | BusinessKorea | ||
| 19.05. | IDL Diagnostics AB: Gustav Sten appointed CEO of IDL Diagnostics | 214 | GlobeNewswire (Europe) | IDL Diagnostics today announces that the Board of Directors has appointed Gustav Sten as the new Chief Executive Officer (CEO). Gustav Sten will assume the position on May 28, immediately following... ► Artikel lesen | |
| 13.05. | IDL Diagnostics AB: IDL Diagnostics (publ) Interim Report January 1 - March 31, 2026 | 411 | GlobeNewswire (Europe) | A word från the CEO "IDL Diagnostics has started 2026 with the strongest quarter in the company's history, and the clear growth trend that we began to see toward the end of last year has continued.... ► Artikel lesen | |
| 05.03. | IDL Diagnostics AB: Anders Hultman will be stepping down as CEO of IDL Diagnostics | 208 | GlobeNewswire (Europe) | The Board of Directors of IDL Diagnostics AB (publ) ("IDL Diagnostics") and CEO Anders Hultman have today agreed that Anders will be leaving his role as CEO of IDL Diagnostics.
"Anders Hultman has,... ► Artikel lesen | |
| 26.02. | IDL Diagnostics AB: IDL Diagnostics AB (publ) Interim Report January 1st to December 31st, 2025 | 187 | GlobeNewswire (Europe) | A word from the CEO"IDL Diagnostics ends 2025 with a strong quarter, achieving the highest revenue for a single quarter in the company's history. During the year, the number of tests sold in our urology... ► Artikel lesen | |
| 12.11.25 | IDL Diagnostics AB: IDL Diagnostics AB (publ) Interim Report January 1st to September 30th, 2025 | 312 | GlobeNewswire (Europe) | A word from the CEO"We are pleased to report continued progress for our UBC bladder cancer test during the past quarter. UBC tests continue to show steady growth, reflecting the strength of our products... ► Artikel lesen | |
| 10.11.25 | IDL Diagnostics AB: First commercial order from Japanese partner secured for the Chinese market | 257 | GlobeNewswire (Europe) | IDL Diagnostics has secured its first commercial order for TPS CLIA from its Japanese partner, a leading global Japanese IVD company, for deployment within the Chinese market.
"I am happy to announce... ► Artikel lesen |
8 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GILEAD SCIENCES | 128,68 | +0,09 % | Assembly Biosciences: Herpes-Countdown mit Gilead | ||
| TILRAY BRANDS | 3,215 | +0,31 % | Tilray Brands, Inc.: BrewDog Builds Momentum for Next Growth Chapter with Expanded Senior Leadership Team | New appointments strengthen marketing, hospitality, category, and international commercial leadership as BrewDog advances long-term growth under Tilray BrandsELLON, Scotland and LONDON, Sept. 28, 2026... ► Artikel lesen | |
| VERTEX PHARMACEUTICALS | 448,45 | +0,04 % | $100 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth This Much Today | ||
| DIGICANN VENTURES | 0,007 | -26,32 % | XFRA VY3: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| TONIX PHARMACEUTICALS | 7,968 | +0,84 % | Tonix Pharmaceuticals Holding Corp. - 8-K, Current Report | ||
| BAYER | 44,940 | -1,01 % | 90 Milliarden US-Dollar bis 2030: Wie Bayer, Mesoblast und NurExone regenerative Medizin unterschiedlich entwickeln | ||
| MERCK KGAA | 136,90 | +1,82 % | Merck Aktie | Wichtige Durchschnittslinien durchbrochen | Analyse | ||
| NOVO NORDISK | 33,210 | -0,48 % | Novo Nordisk gerät trotz GLP-1 unter Druck - warum Eli Lilly und Co. schon Milliarden in neue Plattformen investieren | ||
| ETON PHARMACEUTICALS | 55,42 | 0,00 % | Eton Pharmaceuticals, Inc. - 8-K, Current Report | ||
| SANOFI | 71,08 | -0,03 % | Laufende Fusionskontrollverfahren: Sanofi, Paris/FR; Erwerb eines Minderheitsanteils an der Cheplapharm SE (Gemeinschaftsunternehmen mit der Braun Invest Holding GmbH, Greifswald) | Datum der Anmeldung:24.09.2026Aktenzeichen:B3-102/26Unternehmen:Sanofi, Paris/FR; Erwerb eines Minderheitsanteils an der Cheplapharm SE (Gemeinschaftsunternehmen mit der Braun Invest Holding GmbH, Greifswald)Produktmärkte:Arzneimittel... ► Artikel lesen | |
| GENERATE BIOMEDICINES | 13,685 | -0,04 % | Generate Biomedicines, Inc.: Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of 'Armored' CAR T Therapy for Ovarian Cancer | Engineered with AI to optimize T-cell function in solid tumors, GB-5267 is the first next-generation cell therapy for ovarian cancer to enter clinical trials First patient treated in new clinical... ► Artikel lesen | |
| SEAPORT THERAPEUTICS | 18,420 | 0,00 % | Seaport Therapeutics Prices Upsized IPO Of 14.16 Mln Shares At $18 Each | WASHINGTON (dpa-AFX) - Seaport Therapeutics, Inc. (SPTX) said it has priced its upsized initial public offering of 14.16 shares at $18 per share, at the top of the target range. The company... ► Artikel lesen | |
| PFIZER | 24,735 | +0,18 % | Litfulo and tilrekimig data bolster Pfizer's immunology plans | ||
| LB PHARMACEUTICALS | 37,080 | +0,24 % | Needham initiates LB Pharmaceuticals stock with buy rating | ||
| ELI LILLY | 1.019,20 | +0,33 % | Eli Lilly's Jaypirca gains additional indication for untreated leukemia, lymphoma |
Das Unternehmen IDL DIAGNOSTICS AB kann der Branche Pharma zugeordnet werden. Der aktuelle Kurs liegt bei 0,020 Euro und damit +4,12 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu IDL DIAGNOSTICS AB finden Sie auf Wallstreet Online.